The COVID-19 Antigen Rapid Test Kit does not differentiate between SARS-CoV and SARS-CoV-2. Results are for identification of SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in upper respiratory specimen during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Negative results do not rule out COVID-19 and should not be used as the sole basis for treatment patient management decisions, including infection control decisions. For invitrodiagnosticuse only. For professional use only.
The COVID-19 Antigen Rapid Test Kit from Mediport Diagnostics is an immunochromatographic intended for the direct and qualitative detection of SARS-CoV-2 nucleocapsid antigens in nasopharyngeal swab and oropharyngeal swab from individuals who are suspected of COVID-19 by their healthcare provider. The test is to be used as an aid in the diagnosis of coronavirus infection disease (COVID-19), which is caused by SARS-CoV-2.
A colored line appears in the top section of the result window to show that the test is working properly. This is the control line (C). Even if the control line is faint, the test should be considered to have been performed properly. If no control line is visible the test is invalid. In case of a positive result, a colored line appears in the lower section of the result window. This is the test line (T). Even if the test line is very faint or not uniform, the test result should be interpreted as a positive result.